Clinical Trials Directory

Trials / Completed

CompletedNCT00259584

Superior Vena Caval Obstruction (SVCO) - Management and Outcome

A Prospective Longitudinal Study of the Management and Outcome of Superior Vena Caval Obstruction (SVCO)

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

All patients with symptomatic malignant SVCO deemed suitable for treatment either with radiation therapy or by stenting will be eligible. They will receive whichever treatment is deemed most clinically appropriate. Symptomatic response, time to onset of palliation, duration of symptom control and survival will be assessed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALManagement and Outcome of SVCO

Timeline

Start date
2001-10-01
Primary completion
2008-10-01
Completion
2008-10-01
First posted
2005-11-29
Last updated
2010-08-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00259584. Inclusion in this directory is not an endorsement.

Superior Vena Caval Obstruction (SVCO) - Management and Outcome (NCT00259584) · Clinical Trials Directory